Kineticos Life Sciences is a growth and venture investor focused on companies striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. We envision a world without Cancer, Rare and Neurodegenerative Diseases, and Antimicrobial Resistance. Kineticos invests in companies focused on significant, unmet medical needs across contract services, manufacturing, equipment, and therapeutic companies. In addition to targeting these disease states and sectors, we look for life science companies utilizing disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi, all technologies dramatically changing how medicine is practiced.
For more information on Kineticos and its capabilities, please visit www.kineticos.com.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 9131 Anson Way,
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.kineticos.com
- Keywords
- Biopharmaceutical Consulting, CRO Consulting, CMO Consulting, Diagnostics Consulting, Lab Consulting, Venture Capital, Growth Equity, Private Equity.
- HQ
- Raleigh, North Carolina
Kineticos Life Sciences Questions
Kineticos Life Sciences's website is http://www.kineticos.com
Kineticos Life Sciences's LinkedIn profile is https://www.linkedin.com/company/kineticos
Kineticos Life Sciences has
21 employees.
View email and phone details for 21
employees at Kineticos Life Sciences.
Kineticos Life Sciences's industry is
Venture Capital and Private Equity Principals
Kineticos Life Sciences's top competitors are
Hula Therapeutics,
Diant Pharma Inc.,
Kinvard Bio,
Kincell Bio,
Promaxo,
Carb-X,
Exmoor Pharma,
Inceptor Bio,
Specific Biologics,
Clarametyx Biosciences.
Kineticos Life Sciences's categories are Venture Capital and Private Equity Principals
Kineticos Life Sciences's founding year is 2012
